By Dr Briony Kate Larance

Conference Abstracts

Peacock A; Gisev N; Memedovic S; Larance B; Brown J; Cairns R; Buckley N; Farrell M; Degenhardt L, 2020, 'Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study', in Drug and Alcohol Dependence, Vol. 206, http://dx.doi.org/10.1016/j.drugalcdep.2019.107697

Campbell G; Bruno R; Lintzeris N; Cohen M; Nielsen S; Hall W; Larance B; Mattick RP; Blyth F; Farrell M; Degenhardt L, 2016, 'DEFINING PROBLEMATIC PHARMACEUTICAL OPIOID USE AMONG PEOPLE PRESCRIBED OPIOIDS FOR CHRONIC NON-CANCER PAIN: DO DIFFERENT MEASURES IDENTIFY THE SAME PATIENTS?', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500082&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nielsen S; Peacock A; Lintzeris N; Bruno R; Larance B; Degenhardt L, 2016, 'OVERDOSE KNOWLEDGE AND PERCEPTIONS OF TAKE-HOME NALOXONE FOR PATIENTS WITH CHRONIC NON-CANCER PAIN', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 56 - 57, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500153&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Moore T; O'Donnell C; Degenhardt L; Campbell G; Nielsen S; Larance B, 2016, 'PHYSICAL HEALTH AND UTILISATION OF ALCOHOL AND OTHER DRUG TREATMENT AMONG A SAMPLE OF CHRONIC NON-CANCER PAIN PATIENTS DEPENDENT ON THEIR OPIOID MEDICATION', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 55 - 56, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500150&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Larance B; Ali R; Farrell M; Peacock A; Bruno R; Lintzeris N; Dobbins T; Degenhardt L, 2016, 'THE IMPACT OF REFORMULATED OXYCONTIN (R) IN AUSTRALIA: KEY FINDINGS FROM THE NATIONAL OPIOID MEDICATIONS ABUSE DETERRENCE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 47 - 47, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gisev N; Pearson S-A; Blanch B; Larance B; Dobbins T; Larney S; Degenhardt L, 2016, 'Initiation Of Strong Prescription Opioids In Australia: Cohort Characteristics And Factors Associated With The Type Of Opioid Initiated', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, Vol. 25, pp. 212 - 213, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385483501355&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Larance B; Cama E; Bruno R; Farrell M; Ali R; Lintzeris N; Peacock A; Kihas I; Hordern T; White N; Degenhardt L, 2014, 'PATTERNS OF OPIOID CONSUMPTION IN A COHORT OF PEOPLE WHO TAMPER WITH PHARMACEUTICAL OPIOIDS: BASELINE FINDINGS FROM THE NATIONAL OPIOID MEDICATION ABUSE DETERRENCE (NOMAD) STUDY', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 33, pp. 38 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page